Truvestments Capital’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
VCM
GS
Truvestments Capital's CDNA Position: Q1 2026 in Review
Truvestments Capital held its CareDx (CDNA) position steady in Q1 2026 at 128 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #999.
Truvestments Capital first reported a position in CDNA in Q3 2018 and has held it in 25 quarters since. The position peaked at $23K in Q2 2019. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Truvestments Capital held 128 shares of CareDx worth $2.22K as of Q1 2026.
- Truvestments Capital left its CareDx share count unchanged in Q1 2026.
- CareDx made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #999 holding.
- Truvestments Capital first reported a position in CareDx in Q3 2018 and has held it in 25 quarters since.
- Truvestments Capital's CareDx position peaked at $23K in Q2 2019.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.